Kangmei Pharma | 600518 - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Dianthus Therapeutics USD 463K 179K 2026-03
Genomma Lab Internacional MXN 2.84B 181M 2026-06
Hypermarcas BRL 1.21B 167.56M 2026-03
Ionis Pharmaceuticals USD 265M 22M 2026-06
IQVIA Holdings USD 1.44B 368M 2026-06
Jiangsu Hengrui CNY 7.05B 224.5M 2026-03
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Moderna USD -566M 792M 2026-03
Organon & Co USD 847M 64M 2026-06
Revvity USD 416.87M 29.21M 2026-06
Sh Fosun Pharma CNY 5.01B 1.69B 2026-03
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.57B 193.9M 2026-06
Wuxi Apptec CNY 9.31B 3.04B 2026-06
Xeris Pharmaceuticals USD 72.55M 404K 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03